ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.86
-0.32%
US Tech 100
20,609.60
1.08%
S&P 500
6,046.97
0.80%
US Dollar vs CAD
1.40499
0.26%
Bitcoin
95,494.45
-1.82%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) News

PCRX

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCRX
DateTimeSourceHeadlineSymbolCompany
11/14/20249:05AMGlobeNewswire Inc.Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
11/12/20247:00AMGlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare ConferencesNASDAQ:PCRXPacira BioSciences Inc
11/06/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
11/06/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
11/06/20243:00PMGlobeNewswire Inc.Pacira BioSciences Reports Third Quarter 2024 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
11/05/20243:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
11/04/20247:00AMGlobeNewswire Inc.Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient SettingsNASDAQ:PCRXPacira BioSciences Inc
10/30/20247:00AMGlobeNewswire Inc.Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024NASDAQ:PCRXPacira BioSciences Inc
10/23/20245:54PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
10/21/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
10/21/20247:00AMGlobeNewswire Inc.Pacira BioSciences Appoints Shawn Cross as Chief Financial OfficerNASDAQ:PCRXPacira BioSciences Inc
10/07/20247:00AMGlobeNewswire Inc.Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PCRXPacira BioSciences Inc
10/03/20247:00AMGlobeNewswire Inc.Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025NASDAQ:PCRXPacira BioSciences Inc
09/27/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
09/26/20247:00AMGlobeNewswire Inc.Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
09/25/20247:15AMPR Newswire (US)DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to ShareholdersNASDAQ:PCRXPacira BioSciences Inc
09/13/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
09/13/20249:17AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
09/09/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
09/09/20243:00PMGlobeNewswire Inc.Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PCRXPacira BioSciences Inc
08/19/20247:25AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/14/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/13/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/13/20247:43AMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PCRXPacira BioSciences Inc
08/12/20247:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/12/20247:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/09/20242:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
08/09/20242:21PMGlobeNewswire Inc.Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New JerseyNASDAQ:PCRXPacira BioSciences Inc
08/02/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
08/02/20249:09AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:PCRX

Your Recent History

BIT
P17X24
BNP Paribas Issuance
BIT
P1PW98
BNP Paribas Issuance
BIT
UC78PH
Unicredit Bank
BIT
UV8C90
UniCredit Bank
BIT
UB591M
Unicredit Bank
BIT
P1U670
BNP Paribas Issuance
BIT
UR9ZPG
UniCredit Bank
BIT
S27837
Societe Generale Effekten
BIT
P1HOB5
BNP Paribas Issuance
BIT
P1D0A8
BNP Paribas Issuance
BIT
UI565A
Unicredit Bank
BOV
ABCB10
ABC BRASIL PN
BIT
P12WV8
BNP PARIBAS ISSUANCE
BIT
UC84G8
Unicredit Bank
BOV
CEBR3F
CEB ON
BOV
MDIA3M
M.DIAS BRANCO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68